Case Study: Otsuka America Pharmaceutical shortens oncology drug development by 3–4 years with Cognizant's AI-driven data science solution

Fast-Tracking Cancer Drug Development Using Data Science

A major pharmaceutical company partnered with Cognizant to modernize its highly manual oncology clinical-trial process, aiming to speed drug development while improving safety and efficacy. The challenge was to shorten lengthy, costly development timelines and make better candidate-selection decisions using data-driven methods.

Cognizant built an automated data-analysis pipeline and AI models to predict drug effectiveness and side effects, producing reusable assets and an AI-enabled evaluation workflow. The solution cut preclinical timelines by 3–4 years, trimmed overall development time by 1–2 years, reduced cost per patient by 8–10% (up to ~10% in total costs), and is being extended into a real-time augmented-intelligence application for ongoing drug evaluation.

Otsuka America Pharmaceutical